Blue Crest Capital Management LTD Insulet Corp Transaction History

Blue Crest Capital Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$276.36 - $326.03 $193,452 - $228,220	700 New	700 $223,000
Q4 2019 Feb 14, 2020	SELL	$144.81 - $186.0 $175,944 - $225,990	-1,215 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$117.35 - $167.95 $142,580 - $204,059	1,215 New	1,215 $200,000
Q4 2018 Feb 14, 2019	SELL	$73.27 - $105.19 $2.14 Million - $3.07 Million	-29,209 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$81.43 - $108.13 $3.67 Million - $4.88 Million	-45,087 Reduced 60.69%	29,209 $3.1 Million
Q2 2018 Aug 14, 2018	BUY	$83.27 - $101.93 $5.98 Million - $7.32 Million	71,857 Added 2946.17%	74,296 $6.37 Million
Q1 2018 May 15, 2018	BUY	$68.49 - $87.2 $167,047 - $212,680	2,439 New	2,439 $211,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.